Anti-MDR and antitumoral action of acetylsalicylic acid on leukaemic cells

Bioscience Reports

Volumn 31, Issue 5, 2011, Pages 391-398

  Carrett Dias, Michele ^a   Votto, Ana Paula De Souza ^a   Filgueira, Daza De Moraes Vaz Batista ^a   Almeida, Daniela Volcan ^a   Vallochi, Adriana Lima ^b   D'Oca, Marcelo Gonçalves Montes ^a   Marins, Luis Fernando ^a   Trindade, Gilma Santos ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Acetylsalicylic acid (ASA); Antioxidant; Death cell; Gene expression; Leukaemia; Multidrug resistance (MDR)

Indexed keywords

ACETYLSALICYLIC ACID; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BCL 2 GENE; CANCER INHIBITION; CANCER RESISTANCE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYCLOOXYGENASE 2 GENE; DRUG CYTOTOXICITY; DRUG EFFECT; ERYTHROLEUKEMIA CELL; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MULTIDRUG RESISTANCE; P53 GENE; CELL SURVIVAL; DRUG EFFECTS; DRUG RESISTANCE; DRUG SCREENING; GENE EXPRESSION; K562 CELL LINE; LYMPHOCYTE; METABOLISM; PHYSIOLOGY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; ASPIRIN; CELL SURVIVAL; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION; HUMANS; K562 CELLS; LYMPHOCYTES; REACTIVE OXYGEN SPECIES;

EID: 80155139713     PISSN: 01448463     EISSN: None     Source Type: Journal    
DOI: 10.1042/BSR20100115     Document Type: Article

References (50)

1. Shiff, S. J., Shivaprasad, P. and Santini, D. L. (2003) Cyclooxygenase inhibitors: drugs for cancer prevention. Curr. Opin. Pharmacol. 3, 352-361 (Pubitemid 36908938)
2. Arango, H. A., Icely, S., Roberts, W. S., Cavanagh, D. and Becker, J. L. (2001) Aspirin effects on endometrial cancer cell growth. Obstet. Gynecol. 97, 423-427 (Pubitemid 32184705)
3. Drake, J. G. and Becker, J. L. (2002) Aspirin-induced inhibition of ovarian tumor cell growth. Obstet. Gynecol. 100, 677-682 (Pubitemid 35300022)
4. Li, M., Lotan, R., Levin, B., Tahara, E., Lippman, S. M. and Xu, X. C. (2000) Aspirin induction of apoptosis in esophageal cancer: a potential for chemoprevention. Cancer Epidemiol. Biomarkers Prevent. 9, 545-549 (Pubitemid 30396174)
5. Schreinemachers, D. M. and Everson, R. B. (1994) Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 5, 138-146 (Pubitemid 24073387)
6. Trindade, G. S., Farias, S. L. A., Rumjanek, V. M. and Capella, M. A. M. (2000) Methylene blue reverts multidrug resistance: sensitivity of multidrug resistant cells to this dye and its photodynamic action. Cancer Lett. 151, 161-167 (Pubitemid 30156790)
7. Burch, S., Bisland, S. K., Bogaards, A., Yee, A. J. M., Whyne, C. M., Finkelstein, J. A. and Wilson, B. C. (2005) Photodynamic therapy for the treatment of vertebral metastases in a rat model of human breast carcinoma. J. Orthop. Res. 23, 995-1003 (Pubitemid 41245421)
8. Subongkot, S., Frame, D., Leslie, W. and Drajer, D. (2003) Selective cyclooxygenase-2 inhibition: a target in cancer prevention and treatment. Pharmacotherapy 23, 9-28 (Pubitemid 36077363)
9. Antunes, L. M. G., Bueno, R. B. L., Dias, F. L. and Bianchi, M. L. P. (2007) Acetylsalicylic acid exhibits anticlastogenic effects on cultured human lymphocytes exposed to doxorubicin. Genet. Toxicol. Environ. Mutagen. 626, 155-161 (Pubitemid 44881411)
10. Hsu, C. S. and Li, Y. (2002) Aspirin potently inhibits oxidative DNA strand breaks: implications for cancer chemoprevention. Biochem. Biophys. Res. Commun. 293, 705-709
11. Kerr, J. F., Winterford, C. M. and Harmon, B. V. (1994) Apoptosis. Its significance in cancer and cancer therapy. Cancer 73, 2013-2026 (Pubitemid 24107952)
12. Reed, J. C., Jurgensmeier, J. M. and Matsuyama, S. (1998) Bcl-2 family proteins and mitochondria. Biochim. Biophys. Acta 1366, 127-137 (Pubitemid 28467027)
13. Dole, M., Nuñez, G., Merchant, A. K., Maybaum, J., Rode, C. K., Bloch, C. A. and Castle, V. P. (1994) Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res. 54, 3253-3259 (Pubitemid 24208938)
14. Moll, U. M., Wolff, S., Speidel, D. and Deppert, W. (2005) Transcription-independent pro-apoptotic functions of p53. Curr. Opin. Cell Biol. 17, 631-636 (Pubitemid 41540413)
15. Lane, D. P. (1992) Cancer. p53, guardian of the genome. Nature 358, 15-16
16. Gottesman, M. M. and Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, 385-427 (Pubitemid 23237876)
17. Kartner, N. and Ling, V. (1989) Multidrug resistance in cancer. Sci. Am. 260, 44-51
18. Tiirikainen, M. I. and Krusius, T. (1991) Multidrug resistance. Ann. Med. 23, 509-520
19. Neyfakh, A. A. (1988) Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp. Cell Res. 174, 168-176
20. Ford, J. M. and Hait, W. N. (1990) Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacol. Rev. 42, 155-199 (Pubitemid 20291782)
21. Sikic, B. (1993) Modulation of multidrug resistance: at the threshold. J. Clin. Oncol. 11, 1629-1635
22. Rumjanek, V. M., Lucena, M., Campos, M. M., Marques-Silva, V. M. and Maia, R. C. (1994) Multidrug resistance in leukemias: the problem and some approaches to its circumvention. Ciência e Cultura J. Braz. Assoc. Adv. Sci. 46, 63-69
23. Maia, R. C., Silva, E. A. C., Harab, R. C., Lucena, M., Pires, V. and Rumjanek, V. M. (1996a) Sensitivity of vincristine-sensitive K562 and vincristine-resistant K562-Lucena 1 cells to anthracyclines and reversal of multidrug resistance. Braz. J. Med. Biol. Res. 29, 467-472 (Pubitemid 26132980)
24. Maia, R. C., Wagner, K., Cabral, R. H. and Rumjanek, V. M. (1996b) Heparin reverses Rhodamine 123 extrusion by multidrug resistant cells. Cancer Lett. 106, 101-108 (Pubitemid 26306643)
25. Marques-Silva, V. M. (1996) Efeito de Moduladores da Diferenciaç ão Celular no Processo de Resistência à Múltiplas Drogas, Tese de Doutorado, Universidade Federal Fluminense, Niterói, RJ, Brasil
26. Orind, M., Wagner-Souza, K., Maia, R. C. and Rumjanek, V. M. (1997) Modulation of P-glycoprotein on tumour cells. Calcium and Cellular Metabolism: Transport and Regulation (Sotelo, J. R. and Benech, J. C., eds), pp. 117-124, Plenum Press, New York
27. Vogel, A. I. (1971) Química Orgânica-Análise Orgânica Qualitativa, Vol. 1, 3rd edn, pp. 136-154, Ao livro téenico S. A., Rio de Janeiro
28. Trindade, G. S., Capella, M. A. M., Capella, L. S., Affonso-Mitidier, O. R. and Rumjanek, V. M. (1999) Differences in sensitivity to UVC, UVB and UVA radiation of a multidrug-resistant cell line overexpressing P-glycoprotein. Photochem. Photobiol. 69, 694-699 (Pubitemid 129548830)
29. Lankoff, A., Banasik, A., Obe, G., Deperas, M., Kuzminski, K., Tarczynska, M., Jurczak, T. and Wojcik, A. (2003) Effect of microcystin-LR and cyanobacterial extract from Polish reservoir of drinking water on cell cycle progression, mitotic spindle, and apoptosis in CHO-K1 cells. Toxicol. Appl. Pharmacol. 189, 204-213 (Pubitemid 36681554)
30. Myhre, O. and Fonnum, F. (2001) The effect of aliphatic, naphthenic, and aromatic hydrocarbons on production of reactive oxygen species and reactive nitrogen species in rat brain synaptosome fraction: The involvement of calcium, nitric oxide synthase, mitochondria and phospholipase A. Biochem. Pharmacol. 62, 119-128 (Pubitemid 32488983)
31. Quandt, K., Freeh, K., Karas, H., Wingender, E. and Werner, T. (1995) MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res. 23, 4878-4884 (Pubitemid 3008389)
32. Bellosillo, B., Pique, M., Barragán, M., Castaño, E., Villamor, N., Colomer, D., Montserrat, E., Pons, G. and Gil, J. (1998) Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 92, 1406-1414 (Pubitemid 28369055)
33. Rumjanek, V. M., Trindade, G. S., Wagner-Souza, K., Meletti-de-Oliveira, M. C., Marques-Santos, L. F., Maia, R. C. and Capella, M. A. M. (2001) Multidrug-resistance in tumor cells: characterization of the multidrug resistant cell line K562-Lucena 1. Ann. Acad. Bras. Cienc. 73, 57-69
34. Zhang, G. S., Tu, C. Q., Zhang, G. Y., Zhou, G. B. and Zheng, W. L. (2000) Indomethacin induces apoptosis and inhibits proliferation in chronic myeloid leukemia cells. Leukemia Res. 24, 385-392 (Pubitemid 30227238)
35. Kaufmann, S. H. and Earnshaw, W. C. (2000) Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256, 42-49 (Pubitemid 30211165)
36. Klampfer, L., Cammenga, J., Wisniewski, H. G. and Nimer, S. D. (1999) Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines. Blood 93, 2386-2394 (Pubitemid 29153643)
37. Bedi, A., Zehnbauer, B. A., Barber, J. P., Sharkis, S. J. and Jones, R. J. (1994) Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 83, 2038-2044 (Pubitemid 24112713)
38. Ruefli, A. A. and Johnstone, R. W. (2003) A role for P-glycoprotein in regulating cell growth and survival. Clin. Appl. Immunol. Rev. 4, 31-47 (Pubitemid 36814101)
39. Kondo, M., Oya-Ito, T., Kumagai, T., Osawa, T. and Uchida, K. (2001) Cyclopentenone prostaglandins as potential inducers of intracellular oxidative stress. J. Biol. Chem. 276, 12076-12083
40. Wagner-Souza, K., Echevarria-Lima, J., Rodrigues, L. A. P., Reis, M. and Rumjanek, V. M. (2003) Resistance to thapsigargin-induced intracellular calcium mobilization in a multidrug resistant tumour cell line. Mol. Cell. Biochem. 252, 109-116 (Pubitemid 37220739)
41. Tosi, P., Visani, G., Ottaviani, E., Manfroi, S. and Tura, S. (1996) In vitro culture with prednisolone increases BCL-2 protein expression in adult acute lymphoblastic leukemia cells. Am. J. Hematol. 51, 261-264 (Pubitemid 26117540)
42. Yu, Q. (2006) Restoring p53-mediated apoptosis in cancer cells: new opportunities for cancer therapy. Drug Resist. Updates 9, 19-25
43. Cavalcanti Júnior, G. B., Scheiner, M. A. M., Oliveira, J. G. P., Vasconcelos, F. C., Ferreira, A. C. S. and Maia, R. C. (2003) Flow cytometry, immunocytochemistry and Western Blot in measurement of p53 protein expression in tumor cells: a comparative analysis. Rev. Bras. Anal. Clin. 35, 135-142
44. Fritsche, M., Haessler, C. and Brandner, G. (1993) Induction of nuclear accumulation of the tumor suppressor protein p53 by DNA damaging agents. Oncogene 8, 307-318 (Pubitemid 23073746)
45. Oren, M. and Rotter, V. (2010) Mutant p53 gain-of-function in cancer. Cold Spring Harbor Perspect. Biol. 2, a001107
46. Chin, K. V., Ueda, K., Pastan, I. and Gottesman, M. M. (1992) Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 255, 459-462
47. Linn, S. C., Honkoop, A. H., Hoekman, K., Van Der Valk, P., Pinedo, H. M. and Giaccone, G. (1996) p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer. Br. J. Cancer 74, 63-68 (Pubitemid 26231979)
48. Sheehan, K. M., O'Connell, F., O'Grady, A., Conroy, R. M., Leader, M. B., Byrne, M. F., Murray, F. E. and Kay, E. W. (2004) The relationship between cyclooxygenase-2 expression and characteristics of malignant transformation in human colorectal adenomas. Eur. J. Gastroenterol. Hepatol. 16, 619-625 (Pubitemid 38703872)
49. Katzung, B. G. (2002) Farmacologia Básica and Clínica, 8th edn, Guanabara Koogan, Rio de Janeiro
50. Jin, H., Wang, Z., Liu, L., Gao, L., Sun, L., Li, X., Zhao, H., Pan, Y., Shi, H., Liu, N. et al. (2010) R-Flurbiprofen reverses multidrug resistance, proliferation and metastasis in gastric cancer cells by p75 (NTR) induction. Mol. Pharm. 1, 156-168